Novel albumin-binding photodynamic agent EB-Ppa for targeted fluorescent imaging guided tumour photodynamic therapy

The targeted and novel albumin-binding strategy has been attractive in the field of cancer therapy. Herein, we have developed an organic small molecule-based photosensitizer, Evans Blue-Pyropheophorbide-alpha (EB-Ppa), to treat solid tumors with extremely high photodynamic therapeutic efficiency, which is stable in serum-containing aqueous media and can effectively accumulate in the tumor site due to the enhanced permeability and retention (EPR) effect. Particularly, after the photodynamic therapeutic treatment with EB-Ppa, all breast tumors (4T1 cell line) xenografted in nude mice shrink fast due to the singlet oxygen generated by EB-Ppa with laser irradiation. Furthermore, EB-Ppa shows negligible toxicity in major organs. These results demonstrate that EB-Ppa presents the great potential of photodynamic therapy for efficient tumor treatment.

[1]  Hao Liu,et al.  Molecular and Supramolecular Approach to Highly Photocytotoxic Phthalocyanines with Dual Cell Uptake Pathways and Albumin-Enhanced Tumor Targeting. , 2022, ACS applied materials & interfaces.

[2]  A. Qin,et al.  Photo-Enhanced Chemotherapy Performance in Bladder Cancer Treatment via Albumin Coated AIE Aggregates. , 2022, ACS nano.

[3]  Jessica A. Kemp,et al.  Cancer nanotechnology: current status and perspectives , 2021, Nano Convergence.

[4]  F. Bray,et al.  The ever‐increasing importance of cancer as a leading cause of premature death worldwide , 2021, Cancer.

[5]  K. Burgess,et al.  Hows and Whys of Tumor-Seeking Dyes. , 2021, Accounts of chemical research.

[6]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[7]  Min Wei,et al.  Recent advances in innovative strategies for enhanced cancer photodynamic therapy , 2021, Theranostics.

[8]  Juyoung Yoon,et al.  In Vivo-assembled phthalocyanine/albumin supramolecular complexes combined with a hypoxia-activated prodrug for enhanced photodynamic immunotherapy of cancer. , 2020, Biomaterials.

[9]  Xiaoling Luo,et al.  Advances in nanomaterials for photodynamic therapy applications: Status and challenges. , 2020, Biomaterials.

[10]  D. O’Shea,et al.  Synthesis and evaluation of novel chlorophyll a derivatives as potent photosensitizers for photodynamic therapy. , 2019, European journal of medicinal chemistry.

[11]  B. Tang,et al.  Evaluation of Structure-Function Relationships of Aggregation-Induced Emission Luminogens for Simultaneous Dual Applications of Specific Discrimination and Efficient Photodynamic Killing of Gram-Positive Bacteria. , 2019, Journal of the American Chemical Society.

[12]  K. Burgess,et al.  On the Mechanisms of Uptake of Tumor-Seeking Cyanine Dyes. , 2018, Bioconjugate chemistry.

[13]  Fengwei Wang,et al.  cRGD Peptide-Conjugated Pyropheophorbide-a Photosensitizers for Tumor Targeting in Photodynamic Therapy. , 2018, Molecular pharmaceutics.

[14]  Jonathan F. Lovell,et al.  Targeted Nanomaterials for Phototherapy , 2017, Nanotheranostics.

[15]  K. Howard,et al.  Albumin-based drug delivery: harnessing nature to cure disease , 2016, Molecular and Cellular Therapies.

[16]  Ping Gong,et al.  Smart human serum albumin-indocyanine green nanoparticles generated by programmed assembly for dual-modal imaging-guided cancer synergistic phototherapy. , 2014, ACS nano.

[17]  T. Lai,et al.  Optimization of Evans blue quantitation in limited rat tissue samples , 2014, Scientific Reports.

[18]  Liang Cheng,et al.  Functional nanomaterials for phototherapies of cancer. , 2014, Chemical reviews.

[19]  Il Yoon,et al.  Advance in Photosensitizers and Light Delivery for Photodynamic Therapy , 2013, Clinical endoscopy.

[20]  H. van den Bergh,et al.  Like a Bolt from the Blue: Phthalocyanines in Biomedical Optics , 2011, Molecules.

[21]  Wanyi Tai,et al.  Prodrugs for improving tumor targetability and efficiency. , 2011, Advanced drug delivery reviews.

[22]  A. Bugaj.  Targeted photodynamic therapy — a promising strategy of tumor treatment , 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[23]  Hisataka Kobayashi,et al.  Cancer Cell-Selective In Vivo Near Infrared Photoimmunotherapy Targeting Specific Membrane Molecules , 2011, Nature Medicine.

[24]  Matthias Wacker,et al.  Photosensitizer loaded HSA nanoparticles. I: Preparation and photophysical properties. , 2010, International journal of pharmaceutics.

[25]  Hui Li,et al.  Peptide-based pharmacomodulation of a cancer-targeted optical imaging and photodynamic therapy agent. , 2007, Bioconjugate chemistry.

[26]  J. V. van Lier,et al.  Targeted photodynamic therapy via receptor mediated delivery systems. , 2004, Advanced drug delivery reviews.

[27]  Britton Chance,et al.  Pyropheophorbide 2-deoxyglucosamide: a new photosensitizer targeting glucose transporters. , 2003, Bioconjugate chemistry.

[28]  M. Grounds,et al.  Evans Blue Dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability , 2002, Journal of anatomy.

[29]  G. Hortobagyi,et al.  Current status of adjuvant systemic therapy for primary breast cancer: Progress and controversy , 1995, CA: a cancer journal for clinicians.

[30]  K. P. Ghiggino,et al.  Singlet oxygen formation in monomeric and aggregated porphyrin c. , 1989, Journal of photochemistry and photobiology. B, Biology.